Suspension of customs broker licence upheld where prima facie evidence of contraventions and narcotics risk justified emergent action.

The note addresses suspension of a customs broker licence under Regulation 16(1) of the Customs Brokers Licensing Regulations, 2018, finding that available prima facie material-including a vigilance/investigation report, container-scan mismatch, failure to perform instructed 100% examination, unreliable third party documentation, and an importer profile inconsistent with the goods-sufficiently indicated breaches of Regulation 10(d), 10(e), 10(f) and 10(n) and risks of large scale narcotic smuggling; accordingly emergent suspension was permissible pending inquiry. The suspension was also held not vitiated by delay, and the inquiry must proceed within regulatory timelines.

---

---

Issues: (i) Whether suspension of the customs broker's licence under Regulation 16(1) of the Customs Brokers Licensing Regulations, 2018 was justified on the basis of alleged contraventions of Regulation 10(d), 10(e), 10(f) and 10(n) of CBLR, 2018 and available prima facie material; (ii) Whether the suspension order was vitiated by delay or absence of immediate necessity.

Issue (i): Whether suspension under Regulation 16(1) CBLR, 2018 was justified on the available prima facie material and alleged breaches of Regulation 10(d), 10(e), 10(f) and 10(n) of CBLR, 2018.

Analysis: The material before the Tribunal included a vigilance/investigation report forwarded by the investigating agency, record of container scanning showing a scanned mismatch and marking for 100% examination under Public Notice No. 01/2018-19 dated 20.04.2018, and examination records indicating only one bag was opened despite instruction for 100% examination. The documents provided to the broker by a third party did not reliably establish that the third party was authorised, and the importer's trade profile was materially different from the imported goods, which should have prompted heightened verification. The investigation indicated large-scale smuggling involving narcotic drugs, raising national security and public interest concerns. The Tribunal found these prima facie factual and procedural lapses relevant to the obligations imposed by Regulation 10(d), 10(e), 10(f) and 10(n) and sufficient to invoke emergent suspension power under Regulation 16(1) pending completion of inquiry.

Conclusion: Suspension under Regulation 16(1) of the Customs Brokers Licensing Regulations, 2018 was justified on the available prima facie material and alleged contraventions of Regulation 10(d), 10(e), 10(f) and 10(n) of CBLR, 2018; the impugned suspension is upheld.

Issue (ii): Whether the suspension order was vitiated by delay or absence of immediate necessity.

Analysis: The investigative process was conducted by a national investigative agency and the vigilance report was forwarded to the customs authority before suspension was imposed. The suspension was imposed after receipt of the investigation/vigilance report and confirmed subsequently. Given the nature of the alleged offences involving narcotic smuggling and the timeline of receipt of investigative material, the Tribunal found no undue delay or lack of immediate necessity for suspension; precedents addressing delayed suspensions were distinguished on facts.

Conclusion: The suspension order was not vitiated by delay or absence of immediate necessity; the ground of delay is dismissed.

Final Conclusion: The Tribunal dismisses the appeal and upholds the suspension of the customs broker's licence under Regulation 16(1) of the Customs Brokers Licensing Regulations, 2018, while directing that the inquiry proceed in accordance with the timelines prescribed by the Regulations.

Ratio Decidendi: Where prima facie evidence indicates serious contraventions by a customs broker implicating national security or large-scale contraband, and an investigation/vigilance report supports such prima facie findings, suspension under Regulation 16(1) of the Customs Brokers Licensing Regulations, 2018 is a permissible emergent measure pending completion of inquiry.

---